PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2021.1782022542563-571Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young AdultsHee Young Ju, Meerim Park, Jun Ah Lee, Hyeon Jin Park, Seog Yun Park, June Hyuk Kim, Hyun Guy Kang, Hee Chul Yang, Byung-Kiu Parkhttp://e-crt.org/upload/pdf/crt-2021-178.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2021.178, http://e-crt.org/upload/pdf/crt-2021-178.pdf
Pediatric Blood & Cancer10.1002/pbc.24621201360101621-1625Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcomaAnna Raciborska, Katarzyna Bilska, Katarzyna Drabko, Radoslaw Chaber, Monika Pogorzala, Elżbieta Wyrobek, Katarzyna Polczyńska, Elżbieta Rogowska, Carlos Rodriguez-Galindo, Wojciech Wozniakhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.24621, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.24621, http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24621/fullpdf
Frontiers in Oncology10.3389/fonc.2022.804310202212Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory NeuroblastomaJia Zhu, Juan Wang, Feifei Sun, Zijun Zhen, Tingting Chen, Suying Lu, Junting Huang, Yizhuo Zhang, Xiaofei Sunhttps://www.frontiersin.org/articles/10.3389/fonc.2022.804310/full
Pediatric Blood & Cancer10.1002/pbc.248742013615833-839Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group studyRochelle Bagatell, Robin Norris, Ashish M. Ingle, Charlotte Ahern, Stephan Voss, Elizabeth Fox, Anthony R. Little, Brenda J. Weigel, Peter C. Adamson, Susan Blaneyhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.24874, https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.24874
Pediatric Blood & Cancer10.1002/pbc.224072010544538-545Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A Children's Oncology Group phase I consortium studyLars M. Wagner, John P. Perentesis, Joel M. Reid, Matthew M. Ames, Stephanie L. Safgren, Marvin D. Nelson, Ashish M. Ingle, Susan M. Blaney, Peter C. Adamsonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.22407, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.22407, http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22407/fullpdf
Journal of Oncology Pharmacy Practice10.1177/107815521879079820182561343-1348Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experienceSema Büyükkapu Bay, Rejin Kebudi, Omer Görgün, Bülent Zülfikar, Emin Darendeliler, Fatma B. Çakırhttp://journals.sagepub.com/doi/pdf/10.1177/1078155218790798, http://journals.sagepub.com/doi/full-xml/10.1177/1078155218790798, http://journals.sagepub.com/doi/pdf/10.1177/1078155218790798
Pediatric Blood & Cancer10.1002/pbc.267282017651e26728VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcomaBhuvana A. Setty, Joseph R. Stanek, Leo Mascarenhas, Alexandra Miller, Rochelle Bagatell, Fatih Okcu, Lauren Nicholls, David Lysecki, Abha A. Guptahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.26728, https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.26728
Pediatric Blood & Cancer10.1002/pbc.247852013614756-759Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumabRajkumar Venkatramani, Marcio H. Malogolowkin, Leo Mascarenhashttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.24785, https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.24785
Pediatric Blood & Cancer10.1002/pbc.224602010547909-915Extended phase I evaluation of vincristine, irinotecan, temozolomide, and antibiotic in children with refractory solid tumorsRené Y. McNall-Knapp, Cydni N. Williams, Elaine N. Reeves, Richard L. Heideman, William H. Meyerhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.22460, https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.22460
BMC Cancer10.1186/1471-2407-14-6222014141A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumorsJong Hyung Yoon, Mi Mi Kwon, Hyeon Jin Park, Seog Yun Park, Kun Young Lim, Jungnam Joo, Byung-Kiu Parkhttp://link.springer.com/content/pdf/10.1186/1471-2407-14-622.pdf, http://link.springer.com/article/10.1186/1471-2407-14-622/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-14-622, https://link.springer.com/content/pdf/10.1186/1471-2407-14-622.pdf